@article{article, title  = {{A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR Trial}},

 publisher = {{Elsevier}},

 url = {{}},

 year = {{2020}},

 month = {{10}},

 author = {{Peters S and Danson S and Hasan B and Dafni U and Reinmuth N and Majem M and Tournoy KG and Mark MT and Pless M and Cobo M and Rodriguez-Abreu D et al}},

 doi = {{10.1016/j.jtho.2020.06.011}},

 volume = {{15}},

 journal = {{Journal of Thoracic Oncology}},

 issue = {{10}},

 pages = {{1647-1656}},

 note = {{Accessed on 2025/12/07}}}